Unapproved Lung Device Keeps Cystic Fibrosis Patient Alive Long Enough For Transplant

ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, issued the following statement today from ALung Chairman and CEO Peter DeComo: “Yesterday, the Associated Press reported on the … Continued

CFUnite – Cystic Fibrosis Trust International Conference

Videos from CFUnite / CF Trust International Conference, view the videos here. Ed Owen (CEO, Cystic Fibrosis Trust) and Dr Richard Seabrook (Wellcome Trust) Open the event Professor David Lomas, University College London – Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells … Continued

Nontuberculous Mycobacterial Disease Is Not a Contraindication to Lung Transplantation in Patients With Cystic Fibrosis

Whether nontuberculous mycobacterial (NTM) disease is a contraindication to lung transplantation remains controversial. We conducted a nationwide study to evaluate the clinical importance of NTM infection among lung transplant patients with cystic fibrosis (CF) in Denmark and to determine if … Continued